The beginning of a new era in induction treatment for operable non-small cell lung cancer: a narrative review

BACKGROUND AND OBJECTIVE: The survival benefit of induction therapy for non-small cell lung cancer (NSCLC) remains controversial. Recently, the outcomes of systemic therapy for NSCLC have dramatically changed with the advent of molecular target drugs and immune checkpoint inhibitors (ICIs). The pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinohara, Shuichi, Takahashi, Yusuke, Masago, Katsuhiro, Matsushita, Hirokazu, Kuroda, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992625/
https://www.ncbi.nlm.nih.gov/pubmed/36910085
http://dx.doi.org/10.21037/jtd-22-957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992625/
https://www.ncbi.nlm.nih.gov/pubmed/36910085
http://dx.doi.org/10.21037/jtd-22-957

Ejemplares similares